New Pathways to Cardiometabolic Risk: The Endocannabinoid System In this Podcast, you will discover details about the endocannabinoid system (ECS). Emerging evidence shows that this recently characterized endogenous signaling system plays an important role in energy homeostasis. When overactivated, the ECS appears to contribute to the development of cardiometabolic risk factors. This Podcast will present evidence that overactivity of the ECS-in adipose tissue, liver, skeletal muscle, and brain-can lead to the development of cardiometabolic risk factors, including increased intra-abdominal adiposity (IAA) and insulin resistance. Gaining insights into the role of the ECS can help you identify, manage, and monitor patients who are at risk for cardiovascular disease and diabetes. Presenter Robert R. Henry, MD Professor of Medicine University of California, San Diego Chief of Endocrinology, Metabolism   and Diabetes and Director of the   Center for Metabolic Research Veterans Affairs Medical Center San Diego, California Roundtable Moderator Jane Seley, NP, MPH, MSN, CDE Diabetes Nurse Practitioner   and Certified Diabetes Educator New York Presbyterian   - Weill Cornell Medical Center New York, New York Roundtable Discussants Dwight Deter, PA-C Certified Physician Assistant Southwest Endocrine Consultants El Paso, Texas Joseph Largay, PA-C, CDE Certified Physician Assistant,   Certified Diabetes Educator,   and Clinical Instructor University of North Carolina Diabetes Care Center Chapel Hill, North Carolina W. Lane Edwards, Jr, MSN, ARNP, ANP Partner and Clinician Wright Associates Family Healthcare, PLLC Amherst, New Hampshire Adult Nurse Practitioner Partners in Healthcare Education, LLC Ft. Myers, Florida